DTPa-HBV-IPV vaccine for primary vaccination of infants

Journal of Paediatrics and Child Health

Volumn 43, Issue 9, 2007, Pages 587-592

  Nolan, Terry ^a   Lambert, Stephen ^a,b   Roberton, Don ^c,d   Marshall, Helen ^d   Richmond, Peter ^e   Streeton, Catherine ^f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f GLAXOSMITHKLINE   (Australia)

Author keywords

Combined vaccine; DTPa HBV IPV vaccine; Primary vaccination; Schedule

Indexed keywords

BACTERIAL VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HEPATITIS B VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ANOREXIA; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; ASPIRATION PNEUMONIA; ASTHMA; BACTEREMIA; BLOOD SAMPLING; BRONCHIOLITIS; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIPHTHERIA; DOUBLE BLIND PROCEDURE; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; FEBRILE CONVULSION; GASTROENTERITIS; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; INFANT; INFECTION PREVENTION; INFLUENZA VACCINATION; INJECTION SITE; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; IRRITABILITY; MEDICAL ASSESSMENT; NORMAL HUMAN; OTITIS MEDIA; PENIS DISEASE; PERTUSSIS; PHASE 3 CLINICAL TRIAL; POLIOMYELITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; RESTLESSNESS; SAMPLE SIZE; SEIZURE; SIDE EFFECT; SKULL FRACTURE; SLEEP TIME; STREPTOCOCCUS INFECTION; TETANUS; URINARY TRACT INFECTION; VACCINATION; VIRUS INFECTION; VOMITING;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; POLIOVIRUS VACCINE, INACTIVATED; VACCINES, COMBINED;

EID: 34547672638     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2007.01139.x     Document Type: Article

References (18)

1. The Australian Immunisation Handbook, 8th edn. National Health & Medical Research Council, 2003.
2. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States 2001. MMWR Morb. Mortal. Wkly Rep. 2001 50 : 7 10.
3. Yeh SH. PEDIARIX: clinical trials. Expert Rev. Vaccines 2005 4 : 139 45.
4. Zepp F, Schuind A, Meyer C, Sänger R, Kaufhold A, Willems P. Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants. Pediatrics 2002 109 : e58.
5. Usonis V, Bakasenas V. Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? Eur. J. Pediatr. 1999 158 : 398 402.
6. Standard Procedure for Determining Immunity to Poliovirus Using the Microneutralisation Text. WHO/EPI/Gen 93.9. Geneva: WHO.
7. Horby P, Gilmour R, Wang H, Mcintyre P. Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. Commun. Dis. Intell. 2003 27 : 324 41.
8. Schmitt H-J, Schuind A, Knuf M et al. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22 5 05 infants. J. Pediatr. 1996 129 : 695 701.
9. Schmitt H-J, Wirsing von König CH, Neiss A et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 1996 275 : 37 41.
10. Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics 2000 106 : e51.
11. Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S Canadian Paediatric Society/Health Canada Immunization Monitoring Program-Active (IMPACT). Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT. Pediatrics 2003 112 : e348.
12. Murdin AD, Barreto L, Plotkin S. Inactivated poliovirus vaccine: past and present experience. Vaccine 1996 14 : 735 46.
13. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. 2000 49 (RR-5 49 70.
14. Nolan T, Hogg G, Darcy MA, Skeljo M, Carlin J, Boslego J. A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity. Vaccine 2001 19 : 2127 37.
15. Yeh SH, Ward JI, Partridge S et al. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants. Pediatr. Infect. Dis. J. 2001 20 : 973 80.
16. Offit PA, Quarles J, Gerber MA et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics 2002 109 : 124 9.
17. Luman ET, Barker LE, Shaw KM, Mccauley MM, Buehler JW, Pickering LK. Timeliness of childhood vaccinations in the United States days undervaccinated and number of vaccines delayed. JAMA 2005 293 : 1204 11.
18. Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr. Infect. Dis. J. 2006 25 : 507 12.